Gaozhi Chen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Structural Basis

Chronic Kidney Disease

Signaling Pathway

Top Venues

Journal of cardiovascular pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Min Liu, Linting Cheng, Qianru Ye, Huamin Liu, Cong Shu, Haocheng Gao, Xin Liu, Xiuhua Zhang, Gaozhi Chen
Hypericin alleviates Chronic Kidney Disease induced Left Ventricular Hypertrophy via regulation of FGF23-FGFR4 signaling pathway. Journal of cardiovascular pharmacology (2024)
Min Liu, Linting Cheng, Qianru Ye, Huamin Liu, Cong Shu, Haocheng Gao, Xin Liu, Xiuhua Zhang, Gaozhi Chen
Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway. Journal of cardiovascular pharmacology 83 (6) (2024)
Min Liu, Linting Cheng, Qianru Ye, Huamin Liu, Cong Shu, Haocheng Gao, Xin Liu, Xiuhua Zhang, Gaozhi Chen
Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway. Journal of cardiovascular pharmacology 83 (6) (2024)
Lingfeng Chen, Lili Fu, Jingchuan Sun, Zhiqiang Huang, Mingzhen Fang, Allen Zinkle, Xin Liu, Junliang Lu, Zixiang Pan, Yang Wang, Guang Liang, Xiaokun Li, Gaozhi Chen, Moosa Mohammadi
Structural basis for FGF hormone signalling. Nature (2023)